AUPH

Q: What is the price of Aurinia Pharmaceuticals (AUPH) today?

The price of Aurinia Pharmaceuticals (AUPH) today is $ 14.27, with a variation of 97.92% compared to the last year. The price of Aurinia Pharmaceuticals (AUPH) started the year trading around $ 8.98 and today it is at $ 14.27. Follow the real-time price chart, the historical price of Aurinia Pharmaceuticals (AUPH) and international markets.

Q: When does Aurinia Pharmaceuticals (AUPH) pay dividends?

Aurinia Pharmaceuticals (AUPH) did not distribute dividends in the last year.

Q: Is Aurinia Pharmaceuticals (AUPH) worth it?

Currently, Aurinia Pharmaceuticals (AUPH) is priced at $ 14.27, with a P/E of 29.32%%, representing a deviation of 4,334%% from its historical average P/E. In the last year, the stock showed a variation of 97.92% in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%%. The total shareholder return was 97.92%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Aurinia Pharmaceuticals (AUPH) stock?

Investing in stocks of Aurinia Pharmaceuticals (AUPH) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Aurinia Pharmaceuticals (AUPH) yield today?

The yield of Aurinia Pharmaceuticals (AUPH) was 25.73% in the last month, 97.92% in the last year and 3.63% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%%.If you wanted to buy 100 stocks of Aurinia Pharmaceuticals (AUPH) today, the total investment would be $ 1,427.00, based on the current price of $ 14.27.If past performance were to repeat, the return on your investment would be:In 1 year: $ 2,824.32In 5 years: $ 1,478.80In 10 years: $ 6,949.92It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Aurinia Pharmaceuticals Inc.

Price

$ 14.27

variation (12m)

97.92%

p/e

29.32

p/bv

5.30

DIVIDEND YIELD

0.00%

price AUPH

BVMF

AUPH

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of AUPH

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

25.73%

3 months

22.91%

1 year

97.92%

2 years

72.14%

5 years

3.63%

10 years

387.03%

Indicators AUPH

check out the fundamentals of Aurinia Pharmaceuticals shares

P/E

29.32

Sector: -3.73 Industry: -3.73

P/SALES RATIO (PSR)

6.84

Sector: -3.54 Industry: -3.54

P/BV

5.30

Sector: 1.91 Industry: 1.91

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

12.06%

Sector: -64.30% Industry: -64.30%

ROE

18.08%

Sector: -69.15% Industry: -69.15%

ROIC

56.07%

Sector: -2,102.52% Industry: -2,102.52%

NET MARGIN

23.31%

Sector: -43.46% Industry: -43.46%

GROSS MARGIN

89.51%

Sector: 39.78% Industry: 39.78%

OPERATING MARGIN

26.53%

Sector: -42.43% Industry: -42.43%

P/EBITDA

20.55

Sector: -3.65 Industry: -3.65

P/EBIT

26.52

Sector: -3.95 Industry: -3.95

P/ASSET

3.54

Sector: 1.42 Industry: 1.42

BVPS

2.48

Sector: 1.80 Industry: 1.80

EPS

0.45

Sector: -2.15 Industry: -2.15

EQUITY / ASSETS

0.67

Sector: 0.41 Industry: 0.41

CAGR REVENUES 5 YEARS

39.01%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

0.00%

Sector: - Industry: -

FAIR PRICE OF Aurinia Pharmaceuticals ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 14.27

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-64.88%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

AUPH indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market value	net margin
JNJ	17.98	0.00	0.00%	2.71%	$ 451.67 B	27.26%
PFE	12.81	1.55	12.08%	7.06%	$ 137.69 B	16.84%
ABBV	102.44	-2,793.44	-2,726.81%	2.97%	$ 385.49 B	6.45%
NVO	13.47	8.46	62.86%	3.41%	$ 219.95 B	35.63%
MRK	11.28	0.00	0.00%	3.77%	$ 214.78 B	29.63%
AZN	30.79	5.70	18.51%	1.90%	$ 255.44 B	14.68%
BMY	15.32	4.97	32.47%	5.46%	$ 92.53 B	12.57%
GILD	18.36	6.94	37.80%	2.62%	$ 148.90 B	27.88%
ZTS	24.55	12.88	52.48%	1.34%	$ 64.12 B	27.83%
HALO	14.15	23.71	167.47%	0.00%	$ 7.89 B	47.28%
REGN	14.81	2.19	14.79%	0.41%	$ 67.79 B	32.13%
AMGN	24.26	21.61	89.11%	3.15%	$ 160.56 B	18.96%
VRTX	30.07	6.37	21.18%	0.00%	$ 109.37 B	31.86%
MCK	32.05	-117.52	-366.63%	0.36%	$ 101.42 B	0.84%
CAH	28.47	-16.63	-58.40%	1.07%	$ 45.40 B	0.68%
ADMA	17.86	9.37	52.45%	0.00%	$ 3.73 B	44.06%
BIIB	14.10	1.25	8.83%	0.00%	$ 22.68 B	15.98%

comparison of AUPH with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History AUPH

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Aurinia Pharmaceuticals

Aurinia Pharmaceuticals Inc.

Average user rating I10

4.0 (1 people)

Estados Unidos

14 years

Foundation: 2011

2009

Year of debut on the stock exchange - 16 years

62

Employees

The Company Aurinia Pharmaceuticals Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 1.78 Billion, having a net worth of $ 335.30 Millions.

With a total of 62 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 260.12 Millions, which generated a profit in the amount of $ 60.63 Millions.

As for its main indicators, the Company has a P/E ratio of 29.32, a P/BV ratio of 5.30 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker AUPH.

Market value

$ 1.78 Billion

Net worth

$ 335.30 Millions

US$ 335,300,000.00

Assets

$ 502.56 Millions

US$ 502,560,000.00

Total Number of Shares

135.00 Millions

135,000,000

Average Daily Trading Volume

$ 1.56 Million

US$ 1,561,625.52

Sector

Health Care

Industry

Biotechnology

AUPH

AUPH revenue and profits

AUPH results

DRAG THE FRAME TO SEE MORE DATA

AUPH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$ - -0,00% (12M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 841.67 61,11% (12M)

P/L

32.05

0.36%

ROE

-366.63%

P/VP

-117.52

CAH - Cardinal Health

$ 195.34 75,07% (12M)

P/L

28.47

1.07%

ROE

-58.40%

P/VP

-16.63

JNJ - Johnson & Johnson

$ 186.86 22,66% (12M)

P/L

17.98

2.71%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 83.86 --14,45% (12M)

P/L

11.28

3.77%

ROE

0.00%

P/VP

0.00

ABBV - AbbVie

$ 215.89 11,67% (12M)

P/L

102.44

2.97%

ROE

-2,726.81%

P/VP

-2,793.44

PFE - Pfizer

$ 24.30 --3,22% (12M)

P/L

12.81

7.06%

ROE

12.08%

P/VP

1.55

AZN - AstraZeneca

$ 82.03 26,42% (12M)

P/L

30.79

1.90%

ROE

18.51%

P/VP

5.70

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 841.67 61,11% (12 M)

P/L

32.05

0.36%

ROE

-366.63%

P/VP

-117.52

CAH - Cardinal Health

$ 195.34 75,07% (12 M)

P/L

28.47

1.07%

ROE

-58.40%

P/VP

-16.63

JNJ - Johnson & Johnson

$ 186.86 22,66% (12 M)

P/L

17.98

2.71%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 83.86 --14,45% (12 M)

P/L

11.28

3.77%

ROE

0.00%

P/VP

0.00

ABBV - AbbVie

$ 215.89 11,67% (12 M)

P/L

102.44

2.97%

ROE

-2,726.81%

P/VP

-2,793.44

PFE - Pfizer

$ 24.30 --3,22% (12 M)

P/L

12.81

7.06%

ROE

12.08%

P/VP

1.55

AZN - AstraZeneca

$ 82.03 26,42% (12 M)

P/L

30.79

1.90%

ROE

18.51%

P/VP

5.70

Frequently Asked Questions

What is the price of Aurinia Pharmaceuticals (AUPH) today?

The price of Aurinia Pharmaceuticals (AUPH) today is $ 14.27, with a variation of 97.92% compared to the last year. The price of Aurinia Pharmaceuticals (AUPH) started the year trading around $ 8.98 and today it is at $ 14.27. Follow the real-time price chart, the historical price of Aurinia Pharmaceuticals (AUPH) and international markets.

When does Aurinia Pharmaceuticals (AUPH) pay dividends?

Aurinia Pharmaceuticals (AUPH) did not distribute dividends in the last year.

Is Aurinia Pharmaceuticals (AUPH) worth it?

Currently, Aurinia Pharmaceuticals (AUPH) is priced at $ 14.27, with a P/E of 29.32%%, representing a deviation of 4,334%% from its historical average P/E. In the last year, the stock showed a variation of 97.92% in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%%. The total shareholder return was 97.92%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Aurinia Pharmaceuticals (AUPH) stock?

Investing in stocks of Aurinia Pharmaceuticals (AUPH) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Aurinia Pharmaceuticals (AUPH) yield today?

The yield of Aurinia Pharmaceuticals (AUPH) was 25.73% in the last month, 97.92% in the last year and 3.63% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%%.

If you wanted to buy 100 stocks of Aurinia Pharmaceuticals (AUPH) today, the total investment would be $ 1,427.00, based on the current price of $ 14.27.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 2,824.32
In 5 years: $ 1,478.80
In 10 years: $ 6,949.92

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

AUPH

Aurinia Pharmaceuticals Inc.

Price

variation (12m)

p/e

p/bv

DIVIDEND YIELD

Profitability of AUPH

check out the fundamentals of Aurinia Pharmaceuticals shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY Aurinia Pharmaceuticals

Aurinia Pharmaceuticals Inc.

Estados Unidos

14 years

2009

62

PROFIT X PRICE AUPH

AUPH results

AUPH cash flow

evolution of assets - AUPH

AUPH balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

Frequently Asked Questions